Two recent announcements have put Delta-like ligand 3 (DLL3), a high-potential target, into the spotlight. Both Hengrui Pharma and Innovent's ADC innovative...
Detailed Agenda for Day Jan 12.
The China National Intellectual Property Administration(CNIPA), China’s top IP regulator, recently released on its website the "2023 China Patent Survey Report"...